NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Stage IVA Lung Cancer AJCC v8
Explore clinical trials studying Stage IVA Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
63 public trials
9 recruiting studies
Stage IVA Lung Cancer AJCC v8 trial results
NCT03819296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +61 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04771520
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03948100
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +31 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04919382
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +13 more
- Locations
-
- University of Illinois Cancer Center Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
NCT04762199
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Recruiting
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
NCT05493566
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT03582124
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +9 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Recruiting
PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT05234307
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT04073745
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States